13 Diagnostics & Research Stocks Moving In Tuesday's Session

 

Gainers

Interpace Biosciences, Inc. IDXG shares surged 7.7% to $7.62 during Tuesday's regular session. The most recent rating by Oppenheimer, on January 16, is at Outperform, with a price target of $17.00.

NeoGenomics, Inc. NEO shares moved upwards by 4.3% to $34.11. The most recent rating by First Analysis, on January 23, is at Outperform, with a price target of $35.00.

Precipio, Inc. PRPO stock increased by 3.7% to $1.98. The most recent rating by Maxim Group, on November 22, is at Buy, with a price target of $4.00.

Exact Sciences, Inc. EXAS shares moved upwards by 3.6% to $91.11. The most recent rating by Citigroup, on January 07, is at Buy, with a price target of $120.00.

Invitae, Inc. NVTA stock surged 3.2% to $18.74.

OPKO Health, Inc. OPK shares surged 3.2% to $1.62. The most recent rating by Piper Jaffray, on November 25, is at Overweight, with a price target of $2.50.

Quotient, Inc. QTNT stock increased by 3.1% to $8.25.

 

Losers

Co-Diagnostics, Inc. CODX stock plummeted 20.4% to $2.73 during Tuesday's regular session.

Meridian Bioscience, Inc. VIVO stock fell 13.9% to $9.90.

OpGen, Inc. OPGN shares decreased by 10.8% to $1.49.

Neuronetics, Inc. STIM shares decreased by 5.0% to $3.77. The most recent rating by JMP Securities, on November 06, is at Market Outperform, with a price target of $12.00.

DermTech, Inc. DMTK shares plummeted 3.8% to $13.84.

Trinity Biotech, Inc. TRIB stock plummeted 3.4% to $1.13.

Posted In: Intraday UpdateMarketsMoversTrading IdeasDiagnostics & Research StocksTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...